ASPN · Aspen Aerogels Inc
$5.18
+0.07 (+1.27%)
At close · Aug 21
Market Cap
$424.07M
Shares
82.99M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.11
Open$5.40
Day$5.07–5.45
52W close$2.57–8.82
Avg vol 30d1.4M
Short int8.8M · 10.7% float · 9.0d
Short vol37%
Last earningsAug 6, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 7
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 16 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+21%
above
Price vs 50-day avg
−7%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
41%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
+64%
trailing
YTD return
+81%
this year
Relative strength
+53%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +38 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
10.66% of float · ▲ +7.6% MoM · 9.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
180 holders — mid 3-yr range
Squeeze score
60
elevated · 0–100
Fundamentals
Revenue growth
−40%
Y/Y
Gross margin
17%
contracting
EPS growth
−2882%
Y/Y
Free cash flow
$-4.6M
Balance sheet
$135.0M
net cash
Quant / Vol
risk profile
Volatility
101%
annualized · 1-yr
Max drawdown
−71%
past year
ATR
9.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Revenue
· Q3 2026
Initiated
$65M – $80M
prior qtr $49.85M
midpoint +45.4% QoQ
Adjusted EBITDA
· Q3 2026
Non-GAAP
Maintained
$7M – $15M
Jun 30, 2026
$7M – $15M
changed to
Aug 6, 2026
$7M – $15M
Prior guidance
period ended
· from the 8-K filed Feb 25, 2026
Q1 2026 revenue
· Q1 2026
$35M – $40M
Q1 2026 Net loss per share
· Q1 2026
$-0.28 – $-0.24
Q1 2026 Adjusted EBITDA
· Q1 2026
$-13M – $-10M
Q1 2026 Net loss
· Q1 2026
$-23M – $-20M
Guided vs delivered
· last 2 settled
Revenue
2024
guided $350M
$452.7M
Beat +29.3%
Revenue outlook
2023
guided at least $225M
$238.72M
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+21%
Bullish
Price vs 50-day avg
−7%
Bearish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
41%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +38 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
10.66% of float · ▲ +7.6% MoM · 9.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
180 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $5 · 41%
Range high $9
vs 200-day avg +21%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -19.29M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted net loss non-GAAP | -41.21M | Six Months Ended June 30, 2026 | — |
| Cost structure reduction | $75M | Full Year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASPN
this stock
Aspen Aerogels Inc
|
$424.07M | +80.6% | -40.1% | — | 10.7% |
|
LIN
Linde PLC
|
$224.91B | +12.9% | +3.0% | 31.5 | 1.2% |
|
AIQUF
L Air Liquide SA /Fi
|
$123.27B | +3.2% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.98B | +7.1% | +2.1% | 31.9 | 2.6% |
|
ECL
Ecolab Inc.
|
$78.91B | +7.2% | +2.2% | 37.8 | 1.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASPN | -15.8% | -1.0% | +63.8% | +10.4% | +80.6% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -13.9% | -4.3% | +52.6% | +8.3% | +68.7% |
Key facts
CIK
1145986
CUSIP
04523Y105
13F (30d)
168 filings
167 filers
Visit website
Investor relations